These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8854932)

  • 1. [Statistical considerations for weight variation and content uniformity tests].
    Katori N
    Eisei Shikenjo Hokoku; 1994; (112):200-1. PubMed ID: 8854932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exceptional Application of Content Uniformity Test and Weight Variation Test in the Japanese Pharmacopoeia 13 revision and usage of these tests for in-process tests].
    Katori N; Aoyagi N; Kojima S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):204-5. PubMed ID: 9641846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminatory power of the different requirements for uniformity of dosage units in the European pharmacopoeia.
    Limberg J; Savsek M
    Pharmeur Sci Notes; 2006 Dec; 2006(2):45-8. PubMed ID: 17691214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations.
    Senderak ET
    Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical characteristics of the USP content uniformity test.
    Pedersen AO; Torud Y
    Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality of extemporaneously compounded nitroglycerin ointment.
    Azarnoff DL; Lee JC; Lee C; Chandler J; Karlin D
    Dis Colon Rectum; 2007 Apr; 50(4):509-16. PubMed ID: 17476559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A tentative draft of qualitative test of fluoride for adoption to the general tests of eighth revised edition of the Pharmacopoeia of Japan].
    Takashige M
    Eisei Shikenjo Hokoku; 1970; 88():57-60. PubMed ID: 6015304
    [No Abstract]   [Full Text] [Related]  

  • 9. The study of the applicability of content uniformity and weight variation test--the state of commercial tablets and capsules in Japan.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1412-9. PubMed ID: 11724231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the revision of microbial tests in the Pharmacopoeia of Japan].
    Mise K
    Eisei Shikenjo Hokoku; 1994; (112):206-8. PubMed ID: 8854935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net analyte signal based statistical quality control.
    Skibsted ET; Boelens HF; Westerhuis JA; Smilde AK; Broad NW; Rees DR; Witte DT
    Anal Chem; 2005 Nov; 77(22):7103-14. PubMed ID: 16285655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the "system repeatability" specified in the operating conditions for HPLC assay in JP monographs].
    Iwagami S; Yamashita H; Okada S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):197-8. PubMed ID: 10097541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
    Schepers U; Wätzig H
    J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uniformity of unit-dose pharmaceutical preparations. Tests for the specifications of the uniformity of the pharmacopoeias, evaluation of the permitted variability, transfer of specifications to the control of production, variability found in the Italian pharmaceutical production, proposals for future specifications of uniformity].
    Cavatorta L; Cingolani E; Fontani F; Mecarelli E; Melandri MM; Pietra E; Pietra V; Rocchi B
    Boll Chim Farm; 1973 Apr; 112(4):226-45. PubMed ID: 4721646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Formulation and evaluation of a new content uniformity testing scheme by variables].
    Zhong DF; Wang X; Luo X
    Yao Xue Xue Bao; 1993; 28(1):62-7. PubMed ID: 8328274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line content uniformity determination of tablets using low-resolution Raman spectroscopy.
    Wikström H; Romero-Torres S; Wongweragiat S; Williams JA; Grant ER; Taylor LS
    Appl Spectrosc; 2006 Jun; 60(6):672-81. PubMed ID: 16808869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis of the USP 18 content uniformity sampling plan for tablets.
    Langenbucher F
    Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on eliminating the influence of random errors of analytical methods on the content uniformity test].
    Luo X; Wang X; Tao QF
    Yao Xue Xue Bao; 1989; 24(9):697-701. PubMed ID: 2618720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements.
    Moes JJ; Ruijken MM; Gout E; Frijlink HW; Ugwoke MI
    Int J Pharm; 2008 Jun; 357(1-2):108-18. PubMed ID: 18394831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.